» Articles » PMID: 27405805

The Use of Gabapentin in the Management of Postoperative Pain After Total Hip Arthroplasty: a Meta-analysis of Randomised Controlled Trials

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2016 Jul 14
PMID 27405805
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pain management after total hip arthroplasty (THA) varies and has been widely studied in recent years. Gabapentin as a third-generation antiepileptic drug that selectively affects the nociceptive process has been used for pain relief after THA. This meta-analysis was conducted to examine the efficacy of gabapentin in THA.

Methods: An electronic-based search was conducted using the following databases: PubMed, EMBASE, Ovid MEDLINE, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials (CENTRAL). Randomised controlled trials (RCTs) involving gabapentin and a placebo for THA were included. The meta-analysis was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.

Results: Five trials met the inclusion criteria. The cumulative narcotic consumption and the visual analogue scale (VAS) scores at 24 and 48 h postoperatively were used for postoperative pain assessment. There was a significant decrease in morphine consumption at 24 h (P = 0.00). Compared with the control group, the VAS score (at rest) at 48 h was less in the gabapentin group (P = 0.00).

Conclusion: The administration of gabapentin is effective in decreasing postoperative narcotic consumption and the VAS score.

Citing Articles

Does preappointment gabapentin affect neurological examination findings? A prospective, randomized and blinded study in healthy cats.

de Azevedo A, Veronezi T, Zardo I, Ferronatto J, Franck K, Spiering A J Feline Med Surg. 2023; 25(2):1098612X221149384.

PMID: 36790148 PMC: 10812070. DOI: 10.1177/1098612X221149384.


Opioid Use Consequences, Governmental Strategies, and Alternative Pain Control Techniques Following Total Hip Arthroplasties.

Berardino K, Carroll A, Popovsky D, Ricotti R, Civilette M, Sherman W Orthop Rev (Pavia). 2022; 14(4):35318.

PMID: 35769656 PMC: 9235447. DOI: 10.52965/001c.35318.


Opioid sparing strategies for perioperative pain management other than regional anaesthesia: A narrative review.

Ghai B, Jafra A, Bhatia N, Chanana N, Bansal D, Mehta V J Anaesthesiol Clin Pharmacol. 2022; 38(1):3-10.

PMID: 35706649 PMC: 9191794. DOI: 10.4103/joacp.JOACP_362_19.


The efficacy of perioperative gabapentin for the treatment of postoperative pain following total knee and hip arthroplasty: a meta-analysis.

Kang J, Zhao Z, Lv J, Sun L, Lu B, Dong B J Orthop Surg Res. 2020; 15(1):332.

PMID: 32799902 PMC: 7429897. DOI: 10.1186/s13018-020-01849-6.


Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations.

Wainwright T, Gill M, McDonald D, Middleton R, Reed M, Sahota O Acta Orthop. 2019; 91(1):3-19.

PMID: 31663402 PMC: 7006728. DOI: 10.1080/17453674.2019.1683790.


References
1.
Peng P, Wijeysundera D, Li C . Use of gabapentin for perioperative pain control -- a meta-analysis. Pain Res Manag. 2007; 12(2):85-92. PMC: 2670715. DOI: 10.1155/2007/840572. View

2.
Andersen L, Gaarn-Larsen L, Kristensen B, Husted H, Otte K, Kehlet H . Subacute pain and function after fast-track hip and knee arthroplasty. Anaesthesia. 2009; 64(5):508-13. DOI: 10.1111/j.1365-2044.2008.05831.x. View

3.
Ho K, Gan T, Habib A . Gabapentin and postoperative pain--a systematic review of randomized controlled trials. Pain. 2006; 126(1-3):91-101. DOI: 10.1016/j.pain.2006.06.018. View

4.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62(10):1006-12. DOI: 10.1016/j.jclinepi.2009.06.005. View

5.
Ajori L, Nazari L, Mazloomfard M, Amiri Z . Effects of gabapentin on postoperative pain, nausea and vomiting after abdominal hysterectomy: a double blind randomized clinical trial. Arch Gynecol Obstet. 2011; 285(3):677-82. DOI: 10.1007/s00404-011-2023-6. View